Oxycyte blood substitute shows promise in study:
This article was originally published in Clinica
Executive Summary
Synthetic Blood International says that an animal trial of its blood substitute, Oxycyte, has produced positive results. During the study, Oxycyte was used to replace 30% of the circulating blood volume in anaesthetised rats. At a 15-day follow-up, all animals were found to have survived and appeared well, reports the Costa Mesa, California company. Furthermore, despite a 22% drop in haemoglobin concentration, post-transfusion arterial blood oxygenation levels increased by 38%, it adds. The findings support the use of Oxycyte, a perfluorocarbon-based oxygen carrier, in treating blood loss in trauma and surgery in humans, says company president Robert Nicora.